<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Front Nutr</journal-id><journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id><journal-title-group><journal-title>Frontiers in Nutrition</journal-title></journal-title-group><issn pub-type="epub">2296-861X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6468274</article-id><article-id pub-id-type="doi">10.3389/fnut.2019.00036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Nutrition</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Host- and Microbe-Dependent Dietary Lipid Metabolism in the Control of Allergy, Inflammation, and Immunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Saika</surname><given-names>Azusa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/708375/overview"/></contrib><contrib contrib-type="author"><name><surname>Nagatake</surname><given-names>Takahiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/708356/overview"/></contrib><contrib contrib-type="author"><name><surname>Kunisawa</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/47578/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition</institution>, <addr-line>Osaka</addr-line>, <country>Japan</country></aff><aff id="aff2"><sup>2</sup><institution>Graduate School of Pharmaceutical Sciences, Osaka University</institution>, <addr-line>Osaka</addr-line>, <country>Japan</country></aff><aff id="aff3"><sup>3</sup><institution>International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff><aff id="aff4"><sup>4</sup><institution>Graduate School of Medicine, Graduate School of Dentistry, Osaka University</institution>, <addr-line>Osaka</addr-line>, <country>Japan</country></aff><aff id="aff5"><sup>5</sup><institution>Graduate School of Medicine, Kobe University</institution>, <addr-line>Kobe</addr-line>, <country>Japan</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Thea Magrone, University of Bari Aldo Moro, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Nobuhiko Kamada, University of Michigan Health System, United States; Alberto Finamore, Council for Agricultural and Economics Research, Italy</p></fn><corresp id="c001">*Correspondence: Jun Kunisawa <email>kunisawa@nibiohn.go.jp</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Nutrition</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>6</volume><elocation-id>36</elocation-id><history><date date-type="received"><day>04</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>14</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Saika, Nagatake and Kunisawa.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Saika, Nagatake and Kunisawa</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The intestine is the largest immune organ in the body, provides the first line of defense against pathogens, and prevents excessive immune reactions to harmless or beneficial non-self-materials, such as food and intestinal bacteria. Allergic and inflammatory diseases in the intestine occur as a result of dysregulation of immunological homeostasis mediated by intestinal immunity. Several lines of evidence suggest that gut environmental factors, including nutrition and intestinal bacteria, play important roles in controlling host immune responses and maintaining homeostasis. Among nutritional factors, &#x003c9;3 and &#x003c9;6 essential polyunsaturated fatty acids (PUFAs) profoundly influence the host immune system. Recent advances in lipidomics technology have led to the identification of lipid mediators derived from &#x003c9;3- and &#x003c9;6-PUFAs. In particular, lipid metabolites from &#x003c9;3-PUFAs (e.g., eicosapentaenoic acid and docosahexaenoic acid) have recently been shown to exert anti-allergic and anti-inflammatory responses; these metabolites include resolvins, protectins, and maresins. Furthermore, a new class of anti-allergic and anti-inflammatory lipid metabolites of 17,18-epoxyeicosatetraenoic acid has recently been identified in the control of allergic and inflammatory diseases in the gut and skin. Although these lipid metabolites were found to be endogenously generated in the host, accumulating evidence indicates that intestinal bacteria also participate in lipid metabolism and thus generate bioactive unique lipid mediators. In this review, we discuss the production machinery of lipid metabolites in the host and intestinal bacteria and the roles of these metabolites in the regulation of host immunity.</p></abstract><kwd-group><kwd>lipid metabolites</kwd><kwd>dietary oil</kwd><kwd>intestinal immunity</kwd><kwd>inflammation</kwd><kwd>allergy</kwd><kwd>intestinal bacteria</kwd></kwd-group><counts><fig-count count="3"/><table-count count="0"/><equation-count count="0"/><ref-count count="82"/><page-count count="9"/><word-count count="6822"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Lipid composition in organisms differs among species, in accordance with the expression levels of metabolic enzymes and dietary habits. Marine phytoplankton and seaweeds produce a large amount of the &#x003c9;3-polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (<xref rid="B1" ref-type="bibr">1</xref>). Although fish do not generate EPA and DHA per se, they accumulate EPA and DHA by eating phytoplankton (<xref rid="B1" ref-type="bibr">1</xref>). In plants, linseed and perilla contain large amounts of &#x003b1;-linolenic acid, a precursor of EPA and DHA. In contrast, soybean oil and sesame oil contain copious quantities of the &#x003c9;6-PUFA linoleic acid. The difference in the fatty acid composition of plants depends on the expression levels and activities of metabolic enzymes such as &#x00394;12-desaturase and &#x00394;15-desaturase, which are involved in the generation of linoleic acid and &#x003b1;-linolenic acid, respectively (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Because mammals do not have either &#x00394;12 or &#x00394;15-desaturase, &#x003c9;3- and &#x003c9;6-PUFAs are categorized as essential fatty acids that must be obtained from the diet (<xref rid="B3" ref-type="bibr">3</xref>). Therefore, the balance of &#x003c9;3 and &#x003c9;6 lipids in the body largely depends on the quality of the dietary lipid consumed.</p><p>The beneficial effect of dietary &#x003c9;3-PUFAs on human health was first reported in an epidemiological study in 1978 in which Greenland Eskimos, who consume high &#x003c9;3-PUFA diets that include fish, were found to have a lower mortality from coronary heart disease than Danes and Americans, who eat much less &#x003c9;3-PUFAs (<xref rid="B4" ref-type="bibr">4</xref>). Since then, accumulating evidence indicates that EPA and DHA have beneficial effects on the inhibition of various types of inflammatory and allergic diseases, including cardiovascular disease, Alzheimer's disease, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, asthma, and food allergy (<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>). Recent developments in analytical technology, including liquid chromatography (LC) and mass spectrometry (MS), have enabled us to identify EPA- and DHA-derived pro-resolving lipid mediators (SPMs), including resolvins (Rvs), protectins (PDs), maresins (MaRs), and 17,18-epoxyeicosatetraenoic acid (17,18-EpETE) for inhibition of inflammatory and allergic diseases (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B14" ref-type="bibr">14</xref>).</p><p>Dietary lipids are metabolized not only by mammalian enzymes but also by bacterial enzymes. Microorganisms can generate unique lipid metabolites such as conjugated linoleic acids, hydroxy fatty acids, and oxo fatty acids. These bacteria-produced lipid metabolites show biological activity in the context of host health and diseases (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). Here, we review our current understanding of &#x003c9;3- and &#x003c9;6-PUFA-derived lipid mediators in the control of inflammatory and allergic diseases.</p></sec><sec id="s2"><title>&#x003c9;6 Fatty Acid Metabolites Have Opposing Roles in Pro-and Anti-Inflammation</title><p>Dietary lipids are metabolized in the body to lipid mediators, which regulate host immune systems. Arachidonic acid (AA) is a metabolite of linoleic acid, and functions as a direct precursor of bioactive lipid mediators, which are known as eicosanoids. In addition to its biosynthesis in the body from linoleic acid, AA can be obtained from dietary sources, such as meat and eggs. AA is metabolized by cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP), and then converted into lipid mediators, including prostaglandins (PGs), leukotrienes (LTs), thromboxanes (TXs), and lipoxins (LXs) (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref rid="B17" ref-type="bibr">17</xref>). These AA-derived lipid meditators have both pro- and anti-inflammatory effects in the intestine.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Lipid mediators derived from AA, EPA, and DHA. Various kinds of lipid mediators are produced from &#x003c9;6- and &#x003c9;3-PUFAs. AA, EPA, and DHA are converted to bioactive lipid mediators by the enzymatic activities of COX, LOX, and CYP. Lipid mediators exert their biological effects through binding to G-protein-coupled receptors. AA-derived lipid mediators have pro- and anti-inflammatory activities, whereas EPA- and DHA-derived lipid mediators exert anti-inflammatory or pro-resolution activities or both.</p></caption><graphic xlink:href="fnut-06-00036-g0001"/></fig><p>AA is converted into LTB<sub>4</sub> by LOX activity. The LTB<sub>4</sub>-BLT1 axis plays a key role in the development of inflammatory diseases including inflammatory bowel disease by stimulating the recruitment of inflammatory cells and the production of pro-inflammatory cytokines (<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>). LTB<sub>4</sub> also activates another receptor BLT2 which is a high affinity receptor for 12-hydroxy-heptadecatrienoic acid (12-HHT). In contrast to pro-inflammatory role of BLT1, BLT2-deficient mice show transepidermal water loss, suggesting its anti-inflammatory role in the skin (<xref rid="B21" ref-type="bibr">21</xref>). Indeed, BLT2-mediated pathway induced the expression of claudin-4 for enhancement of epithelial barrier (<xref rid="B21" ref-type="bibr">21</xref>).</p><p>AA is converted into PGs by COX activity, which generate PGD<sub>2</sub> and PGE<sub>2</sub> as the representative lipid mediators. The PGD<sub>2</sub>-chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) pathway induces dextran sodium sulfate (DSS)- and trinitrobenzene sulfonic acid (TNBS)-induced colitis (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Eosinophil infiltration into colon is inhibited by CRTH2 antagonist treatment in TNBS-induced colitis (<xref rid="B23" ref-type="bibr">23</xref>). In contrast to pro-inflammatory properties, the PGD<sub>2</sub>-DP axis reduces granulocyte infiltration into the colonic mucosa in the mouse model of TNBS-induced colitis and colitis-associated colorectal cancer (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>) These opposing roles of CRTH2 and DP in chemotaxis are explained by different usage of G proteins. CRTH2 is coupled with G&#x003b1;<sub>i</sub> while DP is coupled with G&#x003b1;<sub>s</sub>, which induces decreased and increased in cAMP levels, respectively (<xref rid="B26" ref-type="bibr">26</xref>). Consistent with these findings when PGD<sub>2</sub> acted on neutrophils CRTH2 pathway, it induced neutrophil migration to the intestinal lamina propria in the DSS-induced colitis model (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>PGE<sub>2</sub> stimulates four distinct types of receptors EP1 to EP4. The PGE<sub>2</sub>-EP2 axis in neutrophils and tumor-associated fibroblasts promotes colon tumorigenesis by inducing expression of inflammation- and growth-related genes, including tumor necrosis factor (TNF)-&#x003b1;, interleukin (IL)-6, and Wnt5A (<xref rid="B27" ref-type="bibr">27</xref>). In contrast to EP2-mediated carcinogenic effects, EP3-mediated signals show anti-carcinogenic effects, which are consistent with different types of G protein pathways; EP2 activates G&#x003b1;<sub>s</sub>, while EP3 activates G&#x003b1;<sub>i</sub> (<xref rid="B27" ref-type="bibr">27</xref>).</p><p>Therefore, it is suggested that the opposing roles in pro- and anti-inflammation of &#x003c9;6-PUFAs derived lipid mediators are determined by target cell types and receptor types.</p><p>In addition to these factors, cellular source of PGD<sub>2</sub> affects in its activity in pro- and anti-inflammation in croton oil-induced skin inflammation model (<xref rid="B28" ref-type="bibr">28</xref>). In the initial phase of the dermatitis when few inflammatory cells exist in the skin, endothelial cells show highest COX-2 activity and produce PGD<sub>2</sub>, which leads to DP activation on endothelial cells, and inhibits vascular leakage. On the other hand, in the late phase of the dermatitis, many types of hematopoietic inflammatory cells produce PGD<sub>2</sub>, which stimulate CRTH2 on inflammatory cells for infiltration to the inflamed skin, and exacerbates skin inflammation (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>). These findings suggest that stage of inflammatory process is a determinant of the effects of AA-derived metabolites through distinct site of the mediator production.</p></sec><sec id="s3"><title>Dietary &#x003c9;3-PUFAs Inhibit the Development of Allergic Disease</title><p>We and others have shown the anti-inflammatory and anti-allergic effects of dietary &#x003c9;3-PUFAs (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>).</p><p>Fish oil is a representative &#x003c9;3-PUFA-rich dietary oil which contains plenty amount of EPA and DHA. Dietary fish oil ameliorated asthma by decreasing eosinophil infiltration, mucus production, and peribronchiolar fibrosis, which was associated with inhibition of cytokine production by downregulation of nuclear factor (NF)-&#x003ba;B and GATA-3 (<xref rid="B30" ref-type="bibr">30</xref>). These anti-allergic effects may be caused by decreased amount of &#x003c9;6-PUFA-derived lipid mediators such as PGD<sub>2</sub>, LTB<sub>4</sub>, and LTE<sub>4</sub> which exacerbate airway inflammation and increasing &#x003c9;3-PUFA-derived lipid mediators, for example, RvD1 is reported to decrease allergic airway responses (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Further, fish oil-fed mice reduced acute allergic skin response in food allergy model sensitized by peanut and whey by reducing mucosal mast cell protease-1 and antigen specific IgE in serum (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>Linseed oil contains large amount of &#x003b1;-linolenic acid, which is converted into EPA and DHA in the body. One study reported that linseed oil-fed mice alleviated pollen-induced allergic conjunctivitis by decreasing the production of &#x003c9;6-PUFA-derived pro-inflammatory lipid mediators, and reducing eosinophil infiltration into the conjunctiva (<xref rid="B13" ref-type="bibr">13</xref>). We also found that linseed oil-fed mice reduced allergic diarrhea in ovalbumin (OVA)-induced food allergy model (<xref rid="B7" ref-type="bibr">7</xref>). In this model, allergic diarrhea occurs as a consequence of a dominant Th2-type environment and the presence of allergen-specific serum IgE, which induces mast cell degranulation in the gut. We found that in linseed oil-fed mice, the Th1&#x02013;Th2 balance, allergen-specific IgE level, and mast cell numbers in the gut did not change compared with those in soybean oil-fed mice in the OVA-induced food allergy model. However, we found that mast cell degranulation was profoundly inhibited in linseed oil-fed mice (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>We also assessed fatty acid composition in intestinal tissues and found that the amounts of &#x003b1;-linolenic acid and its metabolites of EPA and DHA were increased in linseed oil-fed mice when compared with those in soybean oil-fed mice (<xref rid="B7" ref-type="bibr">7</xref>). In contrast, linoleic acid and AA levels were higher in soybean oil-fed mice than linseed oil-fed mice (<xref rid="B7" ref-type="bibr">7</xref>). Imaging MS analysis revealed that increased amounts of &#x003b1;-linolenic acid, EPA and DHA were found in the lamina propria compartment where large numbers of immune cells such as T cells, plasma cells, and dendritic cells are present (<xref rid="B7" ref-type="bibr">7</xref>). These findings collectively demonstrated that the composition of essential fatty acids in dietary oils directly reflect the lipid composition in the gut, which, in turn, may influence the host immune system.</p></sec><sec id="s4"><title>&#x003c9;3 Fatty Acid Metabolites Have Roles in Anti-Inflammation and Pro-Resolution</title><p>EPA and DHA are representative &#x003c9;3-PUFAs, which compete with AA in the AA cascade. Therefore, it has long been considered that the beneficial effects of dietary &#x003c9;3-PUFAs against inflammatory diseases stem from decreased amounts of AA-derived eicosanoids. In addition, recent technology developments in LC and MS have led to the identification of trace and novel lipid mediators, including Rvs, PDs, and MaRs, which are produced from EPA and DHA in the body (<xref rid="B37" ref-type="bibr">37</xref>). These metabolites have anti-inflammatory or pro-resolution properties (or both) and are known as SPMs (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref rid="B37" ref-type="bibr">37</xref>). Although the receptors for SPMs have not been fully elucidated, some SPMs have been shown to interact with specific receptors. For example, Rvs derived from EPA and DHA use distinct types of receptors. RvE1 interacts with BLT1 and ChemR23, while RvD1 interacts with G-protein-coupled receptor (GPR) 32 and ALX (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>).</p><p>Examples of how SPMs affect intestinal inflammation include their involvement in the RvE1&#x02013;ChemR23 axis, which actively inhibits colonic inflammation in the DSS-induced colitis model by suppressing the TNF-&#x003b1;-induced nuclear translocation of NF-&#x003ba;B and the expression of inflammatory cytokines, including TNF-&#x003b1; and IL-12p40, from macrophages (<xref rid="B40" ref-type="bibr">40</xref>). Furthermore, RvE1 and PD1 enhance the resolution of inflammation by stimulating macrophage phagocytosis of apoptotic cells in zymosan-induced peritonitis (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). MaR1 is reported to attenuate both DSS- and TNBS-induced colitis by inhibiting NF-&#x003ba;B activation and inflammatory cytokine production (<xref rid="B43" ref-type="bibr">43</xref>). Thus, multiple types of SPMs exert their anti-inflammatory properties by using different mechanisms for the regulation of colitis.</p></sec><sec id="s5"><title>17,18-Epoxyeicosatetraenoic Acid is a New Class of Anti-Allergy Lipid Mediator</title><p>As mentioned above, dietary linseed oil inhibited the development of food allergy with increased amounts of &#x003b1;-linolenic acid, EPA and DHA in the intestine (<xref rid="B7" ref-type="bibr">7</xref>), which prompted us to investigate mediator profiles by using LC-MS/MS analysis. We found that 17,18-EpETE was the metabolite whose levels increased the most in the gut of linseed oil-fed mice (<xref rid="B7" ref-type="bibr">7</xref>). When 17,18-EpETE was intraperitoneally injected into soybean oil-fed mice, development of allergic diarrhea and degranulation of mast cells were inhibited, which was similar to observation in linseed oil-fed mice (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref rid="B7" ref-type="bibr">7</xref>). Consistent with its action at the late stage of the allergic response, 17,18-EpETE was effective as a prophylactic and a therapeutic treatment for food allergy (<xref rid="B7" ref-type="bibr">7</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>17,18-EpETE is a new class of anti-allergy and anti-inflammatory lipid mediator. 17,18-EpETE is produced by CYP from EPA. 17,18-EpETE suppresses contact hypersensitivity by reducing neutrophil infiltration into the skin by inhibiting Rac activation and migration through GPR40 signaling. 17,18-EpETE also indirectly inhibits the development of food allergy by inhibiting mast cell degranulation. Given that mast cells do not express GPR40, the detailed mechanisms responsible for this inhibition of mast cell degranulation remain unclear.</p></caption><graphic xlink:href="fnut-06-00036-g0002"/></fig></sec><sec id="s6"><title>17,18-EpETE Ameliorates Contact Hypersensitivity Through GPR40-Mediated Inhibition of Neutrophil Migration</title><p>To evaluate the biological role of 17,18-EpETE in the regulation of other types of allergic inflammatory disease, we examined the effect of 17,18-EpETE on the regulation of contact hypersensitivity (CHS) in the hapten-induced CHS model. We found that 17,18-EpETE showed both prophylactic and therapeutic anti-inflammatory effects on CHS in mice and cynomolgus macaques (<xref rid="B44" ref-type="bibr">44</xref>). 17,18-EpETE did not affect T cell or dendritic cell functions, including inducible skin-associated lymphoid tissue formation, but it did selectively inhibit neutrophil infiltration into the skin (<xref rid="B44" ref-type="bibr">44</xref>). Indeed, 17,18-EpETE reduced neutrophil mobility by inhibiting Rac-activation and pseudopod formation in a GPR40-dependent fashion (<xref rid="B44" ref-type="bibr">44</xref>). Consistent with this selective influence on neutrophils, GPR40 was highly expressed by neutrophils, but not T cells or other leukocytes in the skin. It is worth noting that mast cells do not express GPR40; so, given that mast cell degranulation was inhibited by 17,18-EpETE treatment in the food allergy model (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B44" ref-type="bibr">44</xref>), this finding suggests that 17,18-EpETE inhibits mast cell degranulation indirectly (<xref ref-type="fig" rid="F2">Figure 2</xref>). Of note, the activation of GPR40 in intestinal epithelial cells has been reported to improve intestinal barrier function by enhancing occludin expression (<xref rid="B45" ref-type="bibr">45</xref>). Therefore, it is likely that the improvement in intestinal barrier function induced by 17,18-EpETE via GPR40 in epithelial cells led to decreased allergen penetration, which, in turn, resulted in decreased mast cell degranulation and inhibited food allergy development.</p></sec><sec id="s7"><title>Structure-Activity Relationships Among the GPR40-Dependent Anti-Allergic and Anti-Inflammation Effects of 17,18-EpETE</title><p>17,18-EpETE is further metabolized by soluble epoxide hydrolase to 17,18-dihydroxy-eicosatetraenoic acid (17,18-diHETE). However, 17,18-diHETE has little effect on the development of food allergy, and 14,15-epoxyeicosatetraenoic acid (14,15-EpETE), which has an epoxy structure at the &#x003c9;6 position, also lacks the ability to inhibit food allergy (<xref rid="B7" ref-type="bibr">7</xref>). In addition, 17,18-diHETE has little effect on the development of CHS (<xref rid="B44" ref-type="bibr">44</xref>). Although 17,18-EpETE activates GPR40, 17,18-diHETE does not activate GPR40, which is consistent with its lack of anti-allergic and anti-inflammatory properties (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B44" ref-type="bibr">44</xref>). These findings therefore suggest that the 17,18-epoxy ring structure at the &#x003c9;3 position in EPA is important for GPR40-mediated anti-allergic and anti-inflammatory activity.</p><p>17,18-EpETE is synthesized from EPA through the enzymatic activity of CYP and has two isomers, 17(<italic>S</italic>),18(<italic>R</italic>)-EpETE and 17(<italic>R</italic>),18(<italic>S</italic>)-EpETE. Among the CYP subfamilies in mice, five CYP isoforms (Cyp1a2, 2c50, 4a12a, 4a12b, and 4f18) are known to convert EPA into 17,18-EpETE (<xref rid="B46" ref-type="bibr">46</xref>). Cyp1a2 displays high stereoselectivity for producing 17(<italic>R</italic>),18(<italic>S</italic>)-EpETE, whereas Cyp4f18 displays stereoselectivity for producing 17(<italic>S</italic>),18(<italic>R</italic>)-EpETE (<xref rid="B46" ref-type="bibr">46</xref>). In contrast, Cyp2c50, Cyp4a12a, and Cyp4a12b display less stereoselectivity and produce a mixture of 17(<italic>S</italic>),18(<italic>R</italic>)-EpETE and 17(<italic>R</italic>),18(<italic>S</italic>)-EpETE (<xref rid="B46" ref-type="bibr">46</xref>). 17(<italic>R</italic>),18(<italic>S</italic>)-EpETE, but not 17(<italic>S</italic>),18(<italic>R</italic>)-EpETE, is a potent vasodilator (<xref rid="B47" ref-type="bibr">47</xref>). Indeed, 17(<italic>R</italic>),18(<italic>S</italic>)-EpETE activates calcium-activated potassium channels, which lead to relaxation of rat cerebral artery vascular smooth muscle cells (<xref rid="B47" ref-type="bibr">47</xref>). Whether stereoselectivity of 17,18-EpETE contributes to the anti-allergy and anti-inflammatory effects of 17,18-EpETE have not been evaluated in food allergy and CHS, because we used racemic compounds in our studies (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B44" ref-type="bibr">44</xref>). The CYP isoform and polymorphisms determine the metabolic properties of CYP and stereoselectivity. Therefore, the anti-allergic and anti-inflammatory health benefits derived from &#x003c9;3-PUFA intake may be influenced by the expression levels of the various types of CYP in the body.</p><p>CYP is also found in microorganisms. For example, it has been reported that bacterial CYP (e.g., BM-3 derived from <italic>Bacillus megateirum</italic>) metabolizes PUFAs and produces hydroxy and epoxy fatty acids (<xref rid="B48" ref-type="bibr">48</xref>). <italic>Bacillus, Streptomyces, Pseudomonas</italic>, and <italic>Mycobacterium</italic> also have CYP (<xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B53" ref-type="bibr">53</xref>). These findings suggest that many types of microorganisms are involved in lipid metabolism. In addition, other metabolic enzymes, such as COX and LOX, are thought to be expressed by some bacteria, including <italic>Pseudomonas aeruginosa, Shewanella woodyi, Mytococcus fulrus</italic>, and <italic>Burkholderia thailandensis</italic> (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>). Some microorganisms described above are present in environment, suggesting that in addition to mammalian expression of metabolic enzymes, various microorganisms may be a determinant of the efficacy of &#x003c9;3-PUFA in the context of the regulation of inflammation.</p></sec><sec id="s8"><title>Bacterial-Conjugated Linoleic Acid has a Role in Anti-Inflammation</title><p>Intestinal bacteria have been shown to express unique unsaturated fatty acid-metabolic enzymes and to produce bioactive lipid mediators that are not generated by mammalian cells (<xref ref-type="fig" rid="F3">Figure 3</xref>). Ruminal bacteria including <italic>Butyrivibrio, Lactobacillus</italic>, and <italic>Megasphaera</italic> can produce conjugated linoleic acid (CLA), which is an isomer of linoleic acid that has conjugated double bounds (<xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>). It is known that CLA has some isomers such as <italic>cis</italic>-9-<italic>trans</italic>-11-octadecenoic acid (<italic>c</italic>9,<italic>t</italic>11-CLA), <italic>trans</italic>-10-<italic>cis</italic>-12-octadecenoic acid (<italic>t</italic>10,c12-CLA) and <italic>trans</italic>-9-<italic>trans</italic>-11-octadecenoic acid (<italic>t</italic>9,<italic>t</italic>11-CLA). These isomers have different activities for insulin sensitivity and atherosclerosis.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Physiological functions of CLA and HYA. CLA and HYA are produced from linoleic acid by intestinal bacteria. <italic>c</italic>9,<italic>t</italic>11-CLA ameliorates insulin sensitivity and prevents atherosclerosis, <italic>t</italic>10,<italic>c</italic>12-CLA deteriorates insulin sensitivity and promotes atherosclerosis, and <italic>t</italic>9,<italic>t</italic>11-CLA prevents atherosclerosis. HYA enhances intestinal barrier function by increasing occludin expression and inhibiting intestinal inflammation in a GPR40-dependent manner. HYA inhibits atopic dermatitis by increasing claudin-1 expression and enhancing skin barrier function. HYA also inhibits gastric <italic>Helicobacter</italic> infections by blocking the bacterial futalosine pathways.</p></caption><graphic xlink:href="fnut-06-00036-g0003"/></fig><p>For example, <italic>c</italic>9,<italic>t</italic>11-CLA shows beneficial effects on insulin sensitivity by enhancing glucose uptake and adipokine production such as leptin and adiponectin, and on atherosclerosis by suppressing macrophage infiltration and activation, and reducing plaque development through an increase in expression of PPAR&#x003b3;, while <italic>t</italic>10,c12-CLA shows adverse effects through a decrease in expression of PPAR&#x003b3; (<xref rid="B59" ref-type="bibr">59</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>). In addition, <italic>t</italic>10,c12-CLA reduces expression of liver X receptor &#x003b1; (LXR&#x003b1;) which induces expression of ATP-binding cassette (ABC) transporter A1, ABCG1, and sterol regulatory element binding protein 1c which involved in reverse cholesterol transport (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Therefore, <italic>t</italic>10,c12-CLA shows pro-atherosclerosis effects (<xref rid="B66" ref-type="bibr">66</xref>&#x02013;<xref rid="B68" ref-type="bibr">68</xref>). On the other hand, <italic>t</italic>9,<italic>t</italic>11-CLA is effective for the treatment of atherosclerosis by activation of LXR&#x003b1; (<xref rid="B69" ref-type="bibr">69</xref>). These results indicate that each isomers exert different bioactivities through distinct transcriptional regulation and activation of PPAR&#x003b3; and LXR&#x003b1; for the control of insulin sensitivity and atherosclerosis.</p><p>Compared with chemical production, microbial fermentation offers better ways to produce isomer-specific CLAs. The CLA isomers are produced at different ratios, depending on the type of bacteria. <italic>Lactobacillus</italic> strains (<italic>L. acidophilus, L. plantarum, L. casei, L. reuteri, L. rhamnosus</italic>, and <italic>L. pentosus</italic>), <italic>Bifidobacterium</italic> strains (<italic>B. dentium, B. breve</italic>, and <italic>B. lactis</italic>), and <italic>Propionibacterium freudenreichii</italic> can convert linoleic acid to <italic>c</italic>9,<italic>t</italic>11-CLA and <italic>t</italic>10,c12-CLA, and these bacteria produce higher levels of <italic>c</italic>9,<italic>t</italic>11-CLA than of <italic>t</italic>10,c12-CLA (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B70" ref-type="bibr">70</xref>&#x02013;<xref rid="B72" ref-type="bibr">72</xref>). Some <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> strains also produce <italic>t</italic>9,<italic>t</italic>11-CLA with <italic>c</italic>9,<italic>t</italic>11-CLA and/or <italic>t</italic>10,c12-CLA (<xref rid="B57" ref-type="bibr">57</xref>). <italic>L. paracasei</italic> and <italic>B. bifidum</italic> produce <italic>c</italic>9,<italic>t</italic>11-CLA stereoselectively, whereas <italic>Megasphaera eldsenii</italic> produces <italic>t</italic>10,c12-CLA stereoselectively (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B73" ref-type="bibr">73</xref>). Given that these CLAs have different biological activities which depend on their 3D-structure, it is important to select appropriate bacteria as a probiotics or producer for obtaining required beneficial effects.</p></sec><sec id="s9"><title>Bacterial Production of Unique Hydroxy and Oxo Fatty Acids and Their Multiple Biological Activities</title><p><italic>L. plantarum</italic>, an intestinal bacteria, produces hydroxy fatty acids (i.e., 10-hydroxy-<italic>cis</italic>-12-octadecenoic acid [HYA], 10-hydroxy-<italic>trans</italic>-11-octadecenoic acid [HYC], 10-hydroxy-octadecanoic acid [HYB]) and oxo fatty acids (10-oxo-<italic>cis</italic>-12-octadecenoic acid [KetoA], 10-oxo-<italic>trans</italic>-11-octadecenoic acid [KetoC], 10-oxo-octadecanoic acid [KetoB]) as intermediate products of CLA production (<xref rid="B16" ref-type="bibr">16</xref>). Recently, these metabolic intermediates have been shown to contribute to the regulation of host health and diseases. HYA is the first metabolite produced from linoleic acid by <italic>L. plantarum</italic>, and it enhances intestinal barrier function and suppresses the development of DSS-induced colitis in mice in a GPR40-dependent manner (<xref rid="B45" ref-type="bibr">45</xref>). Furthermore, HYA prevents <italic>Helicobacter</italic> infections by blocking their futalosine pathways, which is an alternative menaquinone biosynthetic pathway and an essential metabolic pathway for the growth of <italic>Helicobacter</italic>. Moreover, HYA treatment suppresses the formation of lymphoid follicles in the gastric mucus layer after <italic>H. suis</italic> infection, and therefore HYA treatment protects mice against the formation of gastric mucosa-associated lymphoid tissue lymphoma induced by infection with <italic>Helicobacter</italic> (<xref rid="B74" ref-type="bibr">74</xref>). HYA also ameliorates the pathological scores of atopic dermatitis in NC/Nga mice by decreasing plasma IgE levels and reducing mast cell infiltration into the skin (<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B76" ref-type="bibr">76</xref>). KetoA enhances adiponectin production and glucose uptake in a proliferator-activated receptor &#x003b3; (PPAR&#x003b3;)-dependent manner, and is effective for the prevention and amelioration of metabolic abnormalities associated with obesity (<xref rid="B77" ref-type="bibr">77</xref>).</p><p>The production of these hydroxy and oxo fatty acids depends on the unique bacterial enzymes CLA-HY (unsaturated fatty acid hydratase), CLA-DH (hydroxy fatty acid dehydrogenase), CLA-DC (isomerase), and CLA-ER (enone reductase) in <italic>L. plantarum</italic> AKU1009a (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B78" ref-type="bibr">78</xref>). The hydroxy activity is found not only in <italic>Lactobacillus</italic> but also in a broad spectrum of bacteria. Oleate hydratase belongs to the FAD-dependent myosin cross-reactive antigen (MCRA) protein family, which is found in gram-positive and -negative bacteria; it catalyzes the conversion of linoleic acid to HYA. For example, <italic>Lactobacillus, Bifidobacterium, Streptococcus</italic>, and <italic>Stenotrophomonas</italic> bacteria are reported to have MCRA, and indeed they have the ability to produce HYA (<xref rid="B79" ref-type="bibr">79</xref>&#x02013;<xref rid="B82" ref-type="bibr">82</xref>).</p><p>Together, these findings indicate that intestinal bacteria metabolize dietary lipids and produce lipid metabolites that can regulate host immune systems. Therefore, to obtain beneficial lipid metabolites and regulate intestinal inflammation, we need to consider not only host enzymes but also enzymes produced by intestinal bacteria. In addition, we must consider how dietary lipid intake causes changes in the intestinal microbiota.</p></sec><sec sec-type="conclusions" id="s10"><title>Conclusion</title><p>Recent technological developments in lipidomics research initiated a new era of lipid biology by helping researchers to identify novel lipid metabolites from &#x003c9;3- and &#x003c9;6-PUFAs, which actively regulate the host immune system and play important roles in the control of health and diseases. Given that the production of lipid metabolites is influenced by complex factors, including diet, intestinal bacteria, and enzyme expression, combined studies on nutrition, metabolomics, and the metagenomics of the microbiota, as well as informatics, may provide powerful insights to further our understanding of the lipid network in the host immune system.</p></sec><sec id="s11"><title>Author Contributions</title><p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We thank laboratory members for helpful discussion. The results described in the review were obtained, at least in part, from research supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Japan Society for the Promotion of Science (JSPS; KAKENHI [JP15K19142 to TN; JP15H05790, JP18H02150, JP18H02674, JP17K09604, JP26670241, and JP26293111 to JK]); the Japan Agency for Medical Research and Development (AMED; [JP17ek0410032s0102, JP17ek0210078h0002, JP17ak0101068h0001, JP17gm1010006s0101, JP18ck0106243h0003, and 19ek0410062h0001 to JK]); the Ministry of Health and Welfare of Japan (to JK); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (to JK); grants-in-aid for Scientific Research on Innovative Areas from MEXT (JP23116506, JP16H01373, and JP25116706 to JK); Cross-ministerial Strategic Innovation Promotion Program (SIP); the Ono Medical Research Foundation; and the Canon Foundation (to JK).</p></ack><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>D</given-names></name><name><surname>Cust&#x000f3;dio</surname><given-names>L</given-names></name><name><surname>Barreira</surname><given-names>L</given-names></name><name><surname>Pereira</surname><given-names>H</given-names></name><name><surname>Ben-Hamadou</surname><given-names>R</given-names></name><name><surname>Varela</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Alternative sources of n-3 long-chain polyunsaturated fatty acids in marine microalgae</article-title>. <source>Mar Drugs.</source> (<year>2013</year>) <volume>11</volume>:<fpage>2259</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.3390/md11072259</pub-id><?supplied-pmid 23807546?><pub-id pub-id-type="pmid">23807546</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrinten</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Munchinsky</surname><given-names>MA</given-names></name><name><surname>Rowland</surname><given-names>G</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name></person-group>. <article-title>Two FAD3 desaturase genes control the level of linolenic acid in flax seed</article-title>. <source>Plant Physiol.</source> (<year>2005</year>) <volume>139</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1104/pp.105.064451</pub-id><?supplied-pmid 16113219?><pub-id pub-id-type="pmid">16113219</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>WJ</given-names></name></person-group>. <article-title>Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological advances</article-title>. <source>Nutrients.</source> (<year>2016</year>) <volume>8</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3390/nu8010023</pub-id><?supplied-pmid 26742061?><pub-id pub-id-type="pmid">26742061</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyerberg</surname><given-names>J</given-names></name><name><surname>Bang</surname><given-names>HO</given-names></name><name><surname>Stoffersen</surname><given-names>E</given-names></name><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Vane</surname><given-names>JR</given-names></name></person-group>
<article-title>Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?</article-title>
<source>Lancet.</source> (<year>1978</year>) <volume>312</volume>:<fpage>117</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(78)91505-2</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name></person-group>. <article-title>Fish intake, contaminants, and human health: evaluating the risks and the benefits</article-title>. <source>JAMA.</source> (<year>2006</year>) <volume>296</volume>:<fpage>1885</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1001/jama.296.15.1885</pub-id><?supplied-pmid 17047219?><pub-id pub-id-type="pmid">17047219</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>J</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name></person-group>. <article-title>Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases</article-title>. <source>Allergol Int.</source> (<year>2015</year>) <volume>64</volume>:<fpage>27</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.alit.2014.08.003</pub-id><?supplied-pmid 25572556?><pub-id pub-id-type="pmid">25572556</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunisawa</surname><given-names>J</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Hayasaka</surname><given-names>T</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>R</given-names></name><name><surname>Nagasawa</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Dietary omega3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut</article-title>. <source>Sci Rep.</source> (<year>2015</year>) <volume>5</volume>:<fpage>9750</fpage>. <pub-id pub-id-type="doi">10.1038/srep09750</pub-id><?supplied-pmid 26065911?><pub-id pub-id-type="pmid">26065911</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Yasutomo</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group>. <article-title>Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB<sub>4</sub> production</article-title>. <source>J Med Invest.</source> (<year>2016</year>) <volume>63</volume>:<fpage>187</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.2152/jmi.63.187</pub-id><?supplied-pmid 27644556?><pub-id pub-id-type="pmid">27644556</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Gobbo</surname><given-names>LC</given-names></name><name><surname>Imamura</surname><given-names>F</given-names></name><name><surname>Aslibekyan</surname><given-names>S</given-names></name><name><surname>Marklund</surname><given-names>M</given-names></name><name><surname>Virtanen</surname><given-names>JK</given-names></name><name><surname>Wennberg</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>&#x003c9;-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies</article-title>. <source>JAMA Intern Med.</source> (<year>2016</year>) <volume>176</volume>:<fpage>1155</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2016.2925</pub-id><?supplied-pmid 27357102?><pub-id pub-id-type="pmid">27357102</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>LJ</given-names></name><name><surname>Feng</surname><given-names>RB</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: a mechanism for hepatoprotective effect against alcoholic liver disease</article-title>. <source>Biochim Biophys Acta Mol Basis Dis.</source> (<year>2017</year>) <volume>1863</volume>:<fpage>3190</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.08.026</pub-id><?supplied-pmid 28847514?><pub-id pub-id-type="pmid">28847514</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshatwi</surname><given-names>AA</given-names></name><name><surname>Subash-Babu</surname><given-names>P</given-names></name></person-group>
<article-title>Effects of increasing ratios of dietary omega-6/omega-3 fatty acids on human monocyte immunomodulation linked with atherosclerosis</article-title>. <source>J Funct Foods.</source> (<year>2018</year>) <volume>41</volume>:<fpage>258</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2017.12.020</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group>. <article-title>Very long-chain n-3 fatty acids and human health: fact, fiction and the future</article-title>. <source>Proc Nutr Soc.</source> (<year>2018</year>) <volume>77</volume>:<fpage>52</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1017/S0029665117003950</pub-id><?supplied-pmid 29039280?><pub-id pub-id-type="pmid">29039280</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirakata</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Ohba</surname><given-names>M</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Okuno</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Dietary omega-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T<sub>h</sub>2 immune responses</article-title>. <source>FASEB J.</source> (<year>2018</year>) <volume>33</volume>:<fpage>3392</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201801805R</pub-id><?supplied-pmid 30383446?><pub-id pub-id-type="pmid">30383446</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms</article-title>. <source>FASEB J.</source> (<year>2017</year>) <volume>31</volume>:<fpage>1273</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201601222R</pub-id><?supplied-pmid 28087575?><pub-id pub-id-type="pmid">28087575</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nieuwenhove</surname><given-names>CPV</given-names></name><name><surname>Ter&#x000e1;n</surname><given-names>V</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>SN</given-names></name></person-group>
<source>Conjugated Linoleic and Linolenic Acid Production by Bacteria: Development of Functional Foods</source>. In: <person-group person-group-type="editor"><name><surname>Rigobelo</surname><given-names>E</given-names></name></person-group> editor. Probiotics. <publisher-loc>London</publisher-loc>: <publisher-loc>IntechOpen</publisher-loc> (<year>2012</year>). <pub-id pub-id-type="doi">10.5772/50321</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Hirata</surname><given-names>A</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Kunisawa</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2013</year>) <volume>110</volume>:<fpage>17808</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1312937110</pub-id><?supplied-pmid 24127592?><pub-id pub-id-type="pmid">24127592</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Z&#x000e1;rate</surname><given-names>R</given-names></name><name><surname>el</surname><given-names>Jaber-Vazdekis N</given-names></name><name><surname>Tejera</surname><given-names>N</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>JA</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>C</given-names></name></person-group>. <article-title>Significance of long chain polyunsaturated fatty acids in human health</article-title>. <source>Clin Transl Med.</source> (<year>2017</year>) <volume>6</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s40169-017-0153-6</pub-id><?supplied-pmid 28752333?><pub-id pub-id-type="pmid">28752333</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hicks</surname><given-names>A</given-names></name><name><surname>Monkarsh</surname><given-names>SP</given-names></name><name><surname>Hoffman</surname><given-names>AF</given-names></name><name><surname>Goodnow</surname><given-names>R</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Leukotriene B<sub>4</sub> receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments</article-title>. <source>Expert Opin Investig Drugs.</source> (<year>2007</year>) <volume>16</volume>:<fpage>1909</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1517/13543784.16.12.1909</pub-id><?supplied-pmid 18042000?><pub-id pub-id-type="pmid">18042000</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokomizo</surname><given-names>T</given-names></name></person-group>. <article-title>Two distinct leukotriene B<sub>4</sub> receptors, BLT1 and BLT2</article-title>. <source>J Biochem.</source> (<year>2014</year>) <volume>157</volume>:<fpage>65</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvu078</pub-id><?supplied-pmid 25480980?><pub-id pub-id-type="pmid">25480980</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Yokomizo</surname><given-names>T</given-names></name></person-group>. <article-title>Identification, signaling, and functions of LTB<sub>4</sub> receptors</article-title>. <source>Semin Immunol.</source> (<year>2017</year>) <volume>33</volume>:<fpage>30</fpage>&#x02013;<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2017.07.010</pub-id><?supplied-pmid 29042026?><pub-id pub-id-type="pmid">29042026</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>Y</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>F</given-names></name><name><surname>Koga</surname><given-names>T</given-names></name><name><surname>Kitajima</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Leukotriene B<sub>4</sub> receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins</article-title>. <source>FASEB J.</source> (<year>2015</year>) <volume>30</volume>:<fpage>933</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1096/fj.15-279653</pub-id><?supplied-pmid 26527063?><pub-id pub-id-type="pmid">26527063</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>EM</given-names></name><name><surname>Radnai</surname><given-names>B</given-names></name><name><surname>Jandl</surname><given-names>K</given-names></name><name><surname>Stan&#x0010d;i&#x00107;</surname><given-names>A</given-names></name><name><surname>Parzmair</surname><given-names>GP</given-names></name><name><surname>H&#x000f6;genauer</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Opposing roles of prostaglandin D<sub>2</sub> receptors in ulcerative colitis</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>193</volume>:<fpage>827</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1303484</pub-id><?supplied-pmid 24929001?><pub-id pub-id-type="pmid">24929001</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radnai</surname><given-names>B</given-names></name><name><surname>Sturm</surname><given-names>EM</given-names></name><name><surname>Stan&#x0010d;i&#x00107;</surname><given-names>A</given-names></name><name><surname>Jandl</surname><given-names>K</given-names></name><name><surname>Labocha</surname><given-names>S</given-names></name><name><surname>Ferreir&#x000f3;s</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn's disease</article-title>. <source>J Crohns Colitis.</source> (<year>2016</year>) <volume>10</volume>:<fpage>1087</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw061</pub-id><?supplied-pmid 26928963?><pub-id pub-id-type="pmid">26928963</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajuebor</surname><given-names>MN</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name></person-group>
<article-title>Cyclooxygenase-2-derived prostaglandin D<sub>2</sub> is an early anti-inflammatory signal in experimental colitis</article-title>. <source>Am J Physiol Gastrointest Liver Physiol.</source> (<year>2000</year>) <volume>279</volume>:<fpage>G238</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.2000.279.1.G238</pub-id><pub-id pub-id-type="pmid">10898767</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamuner</surname><given-names>SR</given-names></name><name><surname>Bak</surname><given-names>AW</given-names></name><name><surname>Devchand</surname><given-names>PR</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name></person-group>. <article-title>Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d<sub>2</sub></article-title>. <source>Am J Pathol.</source> (<year>2005</year>) <volume>167</volume>:<fpage>1293</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)61216-3</pub-id><?supplied-pmid 16251413?><pub-id pub-id-type="pmid">16251413</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupczyk</surname><given-names>M</given-names></name><name><surname>Kuna</surname><given-names>P</given-names></name></person-group>
<article-title>Targeting the PGD<sub>2</sub>/CRTH2/DP1 signaling pathway in asthma and allergic disease: current status and future perspectives</article-title>. <source>Drugs.</source> (<year>2017</year>) <volume>77</volume>:<fpage>1281</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/s40265-017-0777-2</pub-id><pub-id pub-id-type="pmid">28612233</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Tsuruyama</surname><given-names>T</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group>. <article-title>Definition of prostaglandin E2-EP2 signals in the colon tumor microenvironment that amplify inflammation and tumor growth</article-title>. <source>Cancer Res.</source> (<year>2015</year>) <volume>75</volume>:<fpage>2822</fpage>&#x02013;<lpage>2832</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-0125</pub-id><?supplied-pmid 26018088?><pub-id pub-id-type="pmid">26018088</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarashina</surname><given-names>H</given-names></name><name><surname>Tsubosaka</surname><given-names>Y</given-names></name><name><surname>Omori</surname><given-names>K</given-names></name><name><surname>Aritake</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Opposing immunomodulatory roles of prostaglandin D<sub>2</sub> during the progression of skin inflammation</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>192</volume>:<fpage>459</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302080</pub-id><?supplied-pmid 24298012?><pub-id pub-id-type="pmid">24298012</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostenis</surname><given-names>E</given-names></name><name><surname>Ulven</surname><given-names>T</given-names></name></person-group>
<article-title>Emerging roles of DP and CRTH2 in allergic inflammation</article-title>. <source>Trends Mol Med.</source> (<year>2006</year>) <volume>12</volume>:<fpage>148</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2006.02.005</pub-id><?supplied-pmid 16545607?><pub-id pub-id-type="pmid">16545607</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bargut</surname><given-names>TCL</given-names></name><name><surname>Ferreira</surname><given-names>TPT</given-names></name><name><surname>Daleprane</surname><given-names>JB</given-names></name><name><surname>Martins</surname><given-names>MA</given-names></name><name><surname>Silva</surname><given-names>PMR</given-names></name><name><surname>Aguila</surname><given-names>MB</given-names></name></person-group>. <article-title>Fish oil has beneficial effects on allergen-induced airway inflammation and hyperreactivity in mice</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e75059</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0075059</pub-id><?supplied-pmid 24040386?><pub-id pub-id-type="pmid">24040386</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Den Elsen</surname><given-names>LW</given-names></name><name><surname>Bol-Schoenmakers</surname><given-names>M</given-names></name><name><surname>van Esch</surname><given-names>BC</given-names></name><name><surname>Hofman</surname><given-names>GA</given-names></name><name><surname>van de Heijning</surname><given-names>BJ</given-names></name><name><surname>Pieters</surname><given-names>RH</given-names></name><etal/></person-group>
<article-title>DHA-rich tuna oil effectively suppresses allergic symptoms in mice allergic to whey or peanut</article-title>. <source>J. Nutr.</source> (<year>2014</year>) <volume>144</volume>:<fpage>1970</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3945/jn.114.198515</pub-id><pub-id pub-id-type="pmid">25342698</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoda</surname><given-names>H</given-names></name><name><surname>Yanai</surname><given-names>R</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Sobrin</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Dietary omega-3 fatty acids suppress experimental autoimmune uveitis in association with inhibition of Th1 and Th17 cell function</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0138241</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0138241</pub-id><?supplied-pmid 26393358?><pub-id pub-id-type="pmid">26393358</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>Stokholm</surname><given-names>J</given-names></name><name><surname>Chawes</surname><given-names>BL</given-names></name><name><surname>Vissing</surname><given-names>NH</given-names></name><name><surname>Bjarnad&#x000f3;ttir</surname><given-names>E</given-names></name><name><surname>Schoos</surname><given-names>AMM</given-names></name><etal/></person-group>. <article-title>Fish oil&#x02013;derived fatty acids in pregnancy and wheeze and asthma in offspring</article-title>. <source>N Engl J Med.</source> (<year>2016</year>) <volume>375</volume>:<fpage>2530</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1503734</pub-id><?supplied-pmid 28029926?><pub-id pub-id-type="pmid">28029926</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><etal/></person-group>. <article-title>&#x003c9;-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity</article-title>. <source>J. Clin. Invest.</source> (<year>2017</year>) <volume>127</volume>:<fpage>1757</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1172/JCI87388</pub-id><?supplied-pmid 28375156?><pub-id pub-id-type="pmid">28375156</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>BD</given-names></name></person-group>. <article-title>Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways</article-title>. <source>Front Immunol.</source> (<year>2012</year>) <volume>3</volume>:<fpage>390</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2012.00390</pub-id><?supplied-pmid 23293638?><pub-id pub-id-type="pmid">23293638</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogerio</surname><given-names>AP</given-names></name><name><surname>Haworth</surname><given-names>O</given-names></name><name><surname>Croze</surname><given-names>R</given-names></name><name><surname>Oh</surname><given-names>SF</given-names></name><name><surname>Uddin</surname><given-names>M</given-names></name><name><surname>Carlo</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses</article-title>. <source>J Immunol.</source> (<year>2012</year>) <volume>189</volume>:<fpage>1983</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1101665</pub-id><?supplied-pmid 22802419?><pub-id pub-id-type="pmid">22802419</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name><name><surname>Chiang</surname><given-names>N</given-names></name><name><surname>Dalli</surname><given-names>J</given-names></name><name><surname>Levy</surname><given-names>BD</given-names></name></person-group>. <article-title>Lipid mediators in the resolution of inflammation</article-title>. <source>Cold Spring Harb Perspect Biol.</source> (<year>2015</year>) <volume>7</volume>:<fpage>a016311</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a016311</pub-id><?supplied-pmid 25359497?><pub-id pub-id-type="pmid">25359497</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>YP</given-names></name><name><surname>Elangovan</surname><given-names>S</given-names></name><name><surname>Chiang</surname><given-names>N</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Resolvin E1 selectively interacts with leukotriene B<sub>4</sub> receptor BLT1 and ChemR23 to regulate inflammation</article-title>. <source>J Immunol.</source> (<year>2007</year>) <volume>178</volume>:<fpage>3912</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3912</pub-id><?supplied-pmid 17339491?><pub-id pub-id-type="pmid">17339491</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamoorthy</surname><given-names>S</given-names></name><name><surname>Recchiuti</surname><given-names>A</given-names></name><name><surname>Chiang</surname><given-names>N</given-names></name><name><surname>Yacoubian</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Resolvin D1 binds human phagocytes with evidence for proresolving receptors</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2010</year>) <volume>107</volume>:<fpage>1660</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0907342107</pub-id><?supplied-pmid 20080636?><pub-id pub-id-type="pmid">20080636</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Nishitani</surname><given-names>Y</given-names></name><name><surname>Nishiumi</surname><given-names>S</given-names></name><name><surname>Masuda</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis</article-title>. <source>Inflamm Bowel Dis.</source> (<year>2010</year>) <volume>16</volume>:<fpage>87</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21029</pub-id><?supplied-pmid 19572372?><pub-id pub-id-type="pmid">19572372</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>JM</given-names></name><name><surname>Chiang</surname><given-names>N</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Resolvin E1 and protectin D1 activate inflammation-resolution programmes</article-title>. <source>Nature.</source> (<year>2007</year>) <volume>447</volume>:<fpage>869</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature05877</pub-id><?supplied-pmid 17568749?><pub-id pub-id-type="pmid">17568749</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Gemperle</surname><given-names>C</given-names></name><name><surname>Rimann</surname><given-names>N</given-names></name><name><surname>Hersberger</surname><given-names>M</given-names></name></person-group>. <article-title>Resolvin D1 polarizes primary human macrophages toward a proresolution phenotype through GPR32</article-title>. <source>J Immunol.</source> (<year>2016</year>) <volume>196</volume>:<fpage>3429</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1501701</pub-id><?supplied-pmid 26969756?><pub-id pub-id-type="pmid">26969756</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcon</surname><given-names>R</given-names></name><name><surname>Bento</surname><given-names>AF</given-names></name><name><surname>Dutra</surname><given-names>RC</given-names></name><name><surname>Bicca</surname><given-names>MA</given-names></name><name><surname>Leite</surname><given-names>DF</given-names></name><name><surname>Calixto</surname><given-names>JB</given-names></name></person-group>. <article-title>Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis</article-title>. <source>J Immunol.</source> (<year>2013</year>) <volume>191</volume>:<fpage>4288</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1202743</pub-id><?supplied-pmid 24038091?><pub-id pub-id-type="pmid">24038091</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagatake</surname><given-names>T</given-names></name><name><surname>Shiogama</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Kikuta</surname><given-names>J</given-names></name><name><surname>Honda</surname><given-names>T</given-names></name><name><surname>Tiwari</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>The 17,18-epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2018</year>) <volume>142</volume>:<fpage>470</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.09.053</pub-id><?supplied-pmid 29288079?><pub-id pub-id-type="pmid">29288079</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>J</given-names></name><name><surname>Mizukure</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>I</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>A gut microbial metabolite of linoleic acid, 10-hydroxy-<italic>cis</italic>-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway</article-title>. <source>J Biol Chem.</source> (<year>2015</year>) <volume>290</volume>:<fpage>2902</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.610733</pub-id><?supplied-pmid 25505251?><pub-id pub-id-type="pmid">25505251</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isobe</surname><given-names>Y</given-names></name><name><surname>Itagaki</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Naoe</surname><given-names>S</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Ikeguchi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid</article-title>. <source>Sci Rep.</source> (<year>2018</year>) <volume>8</volume>:<fpage>7954</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-26325-4</pub-id><?supplied-pmid 29784972?><pub-id pub-id-type="pmid">29784972</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauterbach</surname><given-names>B</given-names></name><name><surname>Barbosa-Sicard</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>MH</given-names></name><name><surname>Honeck</surname><given-names>H</given-names></name><name><surname>K&#x000e4;rgel</surname><given-names>E</given-names></name><name><surname>Theuer</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators</article-title>. <source>Hypertension.</source> (<year>2002</year>) <volume>39</volume>:<fpage>609</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1161/hy0202.103293</pub-id><?supplied-pmid 11882617?><pub-id pub-id-type="pmid">11882617</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capdevila</surname><given-names>JH</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Helvig</surname><given-names>C</given-names></name><name><surname>Falck</surname><given-names>JR</given-names></name><name><surname>Belosludtsev</surname><given-names>Y</given-names></name><name><surname>Truan</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3</article-title>. <source>J Biol Chem.</source> (<year>1996</year>) <volume>271</volume>:<fpage>22663</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.37.22663</pub-id><?supplied-pmid 8798438?><pub-id pub-id-type="pmid">8798438</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>DC</given-names></name><name><surname>Lei</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Jackson</surname><given-names>CJ</given-names></name><name><surname>Warrilow</surname><given-names>AG</given-names></name><etal/></person-group>. <article-title>Streptomyces coelicolor A3 (2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner</article-title>. <source>Appl Environ Microbiol.</source> (<year>2010</year>) <volume>76</volume>:<fpage>1975</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.03000-09</pub-id><?supplied-pmid 20097805?><pub-id pub-id-type="pmid">20097805</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>E</given-names></name><name><surname>Hamberg</surname><given-names>M</given-names></name><name><surname>Busquets</surname><given-names>M</given-names></name><name><surname>D&#x000ed;az</surname><given-names>P</given-names></name><name><surname>Manresa</surname><given-names>A</given-names></name><name><surname>Oliw</surname><given-names>EH</given-names></name></person-group>. <article-title>Biochemical characterization of the oxygenation of unsaturated fatty acids by the dioxygenase and hydroperoxide isomerase of <italic>Pseudomonas aeruginosa</italic> 42A2</article-title>. <source>J Biol Chem.</source> (<year>2010</year>) <volume>285</volume>:<fpage>9339</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.078147</pub-id><?supplied-pmid 20075076?><pub-id pub-id-type="pmid">20075076</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Bogaert</surname><given-names>IN</given-names></name><name><surname>Groeneboer</surname><given-names>S</given-names></name><name><surname>Saerens</surname><given-names>K</given-names></name><name><surname>Soetaert</surname><given-names>W</given-names></name></person-group>. <article-title>The role of cytochrome P450 monooxygenases in microbial fatty acid metabolism</article-title>. <source>FASEB J.</source> (<year>2011</year>) <volume>278</volume>:<fpage>206</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07949.x</pub-id><?supplied-pmid 21156025?><pub-id pub-id-type="pmid">21156025</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>SL</given-names></name><name><surname>Kelly</surname><given-names>DE</given-names></name></person-group>. <article-title>Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?</article-title>
<source>Philos Trans R Soc Lond B. Biol Sci.</source> (<year>2013</year>) <volume>368</volume>:<fpage>20120476</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2012.0476</pub-id><?supplied-pmid 23297358?><pub-id pub-id-type="pmid">23297358</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M</given-names></name><name><surname>Qhanya</surname><given-names>LB</given-names></name><name><surname>Mthakathi</surname><given-names>NT</given-names></name><name><surname>Kgosiemang</surname><given-names>IKR</given-names></name><name><surname>Bamal</surname><given-names>HD</given-names></name><name><surname>Pagadala</surname><given-names>NS</given-names></name><etal/></person-group>. <article-title>Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: special focus on mycobacterial P450s</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>33099</fpage>. <pub-id pub-id-type="doi">10.1038/srep33099</pub-id><?supplied-pmid 27616185?><pub-id pub-id-type="pmid">27616185</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>J</given-names></name><name><surname>Garreta</surname><given-names>A</given-names></name><name><surname>Benincasa</surname><given-names>M</given-names></name><name><surname>Fust&#x000e9;</surname><given-names>MC</given-names></name><name><surname>Busquets</surname><given-names>M</given-names></name><name><surname>Manresa</surname><given-names>A</given-names></name></person-group>. <article-title>Bacterial lipoxygenases, a new subfamily of enzymes? a phylogenetic approach</article-title>. <source>Appl Microbiol Biotechnol.</source> (<year>2013</year>) <volume>97</volume>:<fpage>4737</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-013-4887-9</pub-id><?supplied-pmid 23624657?><pub-id pub-id-type="pmid">23624657</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>JU</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Hong</surname><given-names>SH</given-names></name><name><surname>Oh</surname><given-names>DK</given-names></name></person-group>. <article-title>Characterization of an omega-6 linoleate lipoxygenase from <italic>Burkholderia thailandensis</italic> and its application in the production of 13-hydroxyoctadecadienoic acid</article-title>. <source>Appl Microbiol Biotechnol.</source> (<year>2015</year>) <volume>99</volume>:<fpage>5487</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-6353-8</pub-id><?supplied-pmid 25586578?><pub-id pub-id-type="pmid">25586578</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Liu</surname><given-names>RH</given-names></name></person-group>
<article-title>Increase of conjugated linoleic acid content in milk by fermentation with lactic acid bacteria</article-title>. <source>J Food Sci Technol.</source> (<year>2002</year>) <volume>67</volume>:<fpage>1731</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2621.2002.tb08714.x</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>J</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>A</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name></person-group>. <article-title>Production of conjugated fatty acids by lactic acid bacteria</article-title>. <source>J Biosci Bioeng.</source> (<year>2005</year>) <volume>100</volume>:<fpage>355</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1263/jbb.100.355</pub-id><?supplied-pmid 16310724?><pub-id pub-id-type="pmid">16310724</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puniya</surname><given-names>AK</given-names></name><name><surname>Chaitanya</surname><given-names>S</given-names></name><name><surname>Tyagi</surname><given-names>AK</given-names></name><name><surname>De</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name></person-group>. <article-title>Conjugated linoleic acid producing potential of lactobacilli isolated from the rumen of cattle</article-title>. <source>J Ind Microbiol Biotechnol.</source> (<year>2008</year>) <volume>35</volume>:<fpage>1223</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-008-0429-3</pub-id><?supplied-pmid 18712544?><pub-id pub-id-type="pmid">18712544</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Mclntosh</surname><given-names>MK</given-names></name></person-group>. <article-title>Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity</article-title>. <source>J Nutr.</source> (<year>2003</year>) <volume>133</volume>:<fpage>3041</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/jn/133.10.3041</pub-id><?supplied-pmid 14519781?><pub-id pub-id-type="pmid">14519781</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wargent</surname><given-names>E</given-names></name><name><surname>Sennitt</surname><given-names>MV</given-names></name><name><surname>Stocker</surname><given-names>C</given-names></name><name><surname>Mayes</surname><given-names>AE</given-names></name><name><surname>Brown</surname><given-names>L</given-names></name><name><surname>O'Dowd</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation</article-title>. <source>Lipids Health Dis.</source> (<year>2005</year>) <volume>4</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/1476-511X-4-3</pub-id><?supplied-pmid 15642120?><pub-id pub-id-type="pmid">15642120</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonardini</surname><given-names>A</given-names></name><name><surname>Laviola</surname><given-names>L</given-names></name><name><surname>Perrini</surname><given-names>S</given-names></name><name><surname>Natalicchio</surname><given-names>A</given-names></name><name><surname>Giorgino</surname><given-names>F</given-names></name></person-group>
<article-title>Cross-talk between PPAR and insulin signaling and modulation of insulin sensitivity</article-title>. <source>PPAR Res.</source> (<year>2009</year>) <volume>2009</volume>:<fpage>818945</fpage>
<pub-id pub-id-type="doi">10.1155/2009/818945</pub-id><pub-id pub-id-type="pmid">20182551</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>D</given-names></name><name><surname>Herrmann</surname><given-names>J</given-names></name><name><surname>Much</surname><given-names>D</given-names></name><name><surname>Pfeuffer</surname><given-names>M</given-names></name><name><surname>Laue</surname><given-names>C</given-names></name><name><surname>Winkler</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPAR&#x003b3;2 Pro12Ala polymorphism</article-title>. <source>Genes Nutr.</source> (<year>2012</year>) <volume>7</volume>:<fpage>499</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1007/s12263-012-0289-3</pub-id><?supplied-pmid 22399314?><pub-id pub-id-type="pmid">22399314</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Boysen</surname><given-names>MS</given-names></name><name><surname>Jensen</surname><given-names>SS</given-names></name><name><surname>Morrison</surname><given-names>RF</given-names></name><name><surname>Storkson</surname><given-names>J</given-names></name><name><surname>Lea-Currie</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Isomer-specific regulation of metabolism and PPAR&#x003b3; signaling by CLA in human preadipocytes</article-title>. <source>J Lipid Res.</source> (<year>2003</year>) <volume>44</volume>:<fpage>1287</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M300001-JLR200</pub-id><?supplied-pmid 12730300?><pub-id pub-id-type="pmid">12730300</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granlund</surname><given-names>L</given-names></name><name><surname>Juvet</surname><given-names>LK</given-names></name><name><surname>Pedersen</surname><given-names>JI</given-names></name><name><surname>Nebb</surname><given-names>HI</given-names></name></person-group>. <article-title>Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPAR&#x003b3; modulator</article-title>. <source>J Lipid Res.</source> (<year>2003</year>) <volume>44</volume>:<fpage>1441</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M300120-JLR200</pub-id><?supplied-pmid 12754280?><pub-id pub-id-type="pmid">12754280</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ecker</surname><given-names>J</given-names></name><name><surname>Langmann</surname><given-names>T</given-names></name><name><surname>Moehle</surname><given-names>C</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name></person-group>. <article-title>Isomer specific effects of conjugated linoleic acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism</article-title>. <source>Biochem Biophys Res Commun.</source> (<year>2007</year>) <volume>352</volume>:<fpage>805</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.11.087</pub-id><?supplied-pmid 17141191?><pub-id pub-id-type="pmid">17141191</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbon&#x000e9;s-Mainar</surname><given-names>JM</given-names></name><name><surname>Navarro</surname><given-names>MA</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>MA</given-names></name><name><surname>Arnal</surname><given-names>C</given-names></name><name><surname>Surra</surname><given-names>JC</given-names></name><name><surname>Ac&#x000ed;n</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice</article-title>. <source>Atherosclerosis.</source> (<year>2006</year>) <volume>189</volume>:<fpage>318</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2006.01.015</pub-id><?supplied-pmid 16530768?><pub-id pub-id-type="pmid">16530768</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toomey</surname><given-names>S</given-names></name><name><surname>Harhen</surname><given-names>B</given-names></name><name><surname>Roche</surname><given-names>HM</given-names></name><name><surname>Fitzgerald</surname><given-names>D</given-names></name><name><surname>Belton</surname><given-names>O</given-names></name></person-group>. <article-title>Profound resolution of early atherosclerosis with conjugated linoleic acid</article-title>. <source>Atherosclerosis.</source> (<year>2006</year>) <volume>187</volume>:<fpage>40</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.08.024</pub-id><?supplied-pmid 16182300?><pub-id pub-id-type="pmid">16182300</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Gaetano</surname><given-names>M</given-names></name><name><surname>Alghamdi</surname><given-names>K</given-names></name><name><surname>Marcone</surname><given-names>S</given-names></name><name><surname>Belton</surname><given-names>O</given-names></name></person-group>. <article-title>Conjugated linoleic acid induces an atheroprotective macrophage M&#x003a6;2 phenotype and limits foam cell formation</article-title>. <source>J Inflamm.</source> (<year>2015</year>) <volume>12</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s12950-015-0060-9</pub-id><?supplied-pmid 25722654?><pub-id pub-id-type="pmid">25722654</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ecker</surname><given-names>J</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><name><surname>Patsch</surname><given-names>W</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name></person-group>. <article-title>The conjugated linoleic acid isomer trans-9, trans-11 is a dietary occurring agonist of liver X receptor &#x003b1;</article-title>. <source>Biochem Biophys Res Commun.</source> (<year>2009</year>) <volume>388</volume>:<fpage>660</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2009.08.048</pub-id><?supplied-pmid 19682978?><pub-id pub-id-type="pmid">19682978</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Boylston</surname><given-names>TD</given-names></name><name><surname>Glatz</surname><given-names>BA</given-names></name></person-group>
<article-title>Effect of lipid source on probiotic bacteria and conjugated linoleic acid formation in milk model systems</article-title>. <source>J Am Oil Chem Soc.</source> (<year>2004</year>) <volume>81</volume>:<fpage>589</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1007/s11746-006-0946-z</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Seok</surname><given-names>SH</given-names></name><name><surname>Baek</surname><given-names>MW</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>KE</given-names></name><etal/></person-group>. <article-title>Human originated bacteria, <italic>Lactobacillus rhamnosus</italic> PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice</article-title>. <source>Biochim Biophys Acta Mol Cell Biol Lipids.</source> (<year>2006</year>) <volume>1761</volume>:<fpage>736</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2006.05.007</pub-id><?supplied-pmid 16807088?><pub-id pub-id-type="pmid">16807088</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coakley</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Nordgren</surname><given-names>M</given-names></name><name><surname>Fitzgerald</surname><given-names>G</given-names></name><name><surname>Devery</surname><given-names>R</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group>. <article-title>Conjugated linoleic acid biosynthesis by human-derived <italic>Bifidobacterium</italic> species</article-title>. <source>J Appl Microbiol.</source> (<year>2003</year>) <volume>94</volume>:<fpage>138</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2672.2003.01814.x</pub-id><?supplied-pmid 12492934?><pub-id pub-id-type="pmid">12492934</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TW</given-names></name><name><surname>Choi</surname><given-names>NJ</given-names></name><name><surname>Hwangbo</surname><given-names>J</given-names></name><name><surname>Hsu</surname><given-names>JT</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Song</surname><given-names>MK</given-names></name><etal/></person-group>
<article-title>Production of trans-10, cis-12 conjugated linoleic acid by <italic>Megasphaera elsdenii</italic> YJ-4: physiological roles in the rumen</article-title>. <source>Asian-australas J Anim Sci.</source> (<year>2005</year>) <volume>18</volume>:<fpage>1425</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.5713/ajas.2005.1425</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Murayama</surname><given-names>SY</given-names></name><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group>. <article-title>Protective efficacy of a hydroxy fatty acid against gastric <italic>Helicobacter</italic> infections</article-title>. <source>Helicobacter.</source> (<year>2017</year>) <volume>22</volume>:<fpage>e12430</fpage>. <pub-id pub-id-type="doi">10.1111/hel.12430</pub-id><?supplied-pmid 28834011?><pub-id pub-id-type="pmid">28834011</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaikiri</surname><given-names>H</given-names></name><name><surname>Miyamoto</surname><given-names>J</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Supplemental feeding of a gut microbial metabolite of linoleic acid, 10-hydroxy-<italic>cis</italic>-12-octadecenoic acid, alleviates spontaneous atopic dermatitis and modulates intestinal microbiota in NC/nga mice</article-title>. <source>Int J Food Sci Nutr.</source> (<year>2017</year>) <volume>68</volume>:<fpage>941</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1080/09637486.2017.1318116</pub-id><?supplied-pmid 28438083?><pub-id pub-id-type="pmid">28438083</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name></person-group>. <article-title>Regulation of allergic immune responses by microbial metabolites</article-title>. <source>Immune Netw.</source> (<year>2018</year>) <volume>18</volume>:<fpage>e15</fpage>. <pub-id pub-id-type="doi">10.4110/in.2018.18.e15</pub-id><?supplied-pmid 29503745?><pub-id pub-id-type="pmid">29503745</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>YI</given-names></name><name><surname>Furuzono</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Yamakuni</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>HE</given-names></name><etal/></person-group>. <article-title>10-oxo-12 (Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, potently activates PPAR&#x003b3; and stimulates adipogenesis</article-title>. <source>Biochem Biophys Res Commun.</source> (<year>2015</year>) <volume>459</volume>:<fpage>597</fpage>&#x02013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.02.154</pub-id><?supplied-pmid 25749343?><pub-id pub-id-type="pmid">25749343</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Saika</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Production of dicarboxylic acids from novel unsaturated fatty acids by laccase-catalyzed oxidative cleavage</article-title>. <source>Biosci Biotechnol Biochem.</source> (<year>2016</year>) <volume>80</volume>:<fpage>2132</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1080/09168451.2016.1200457</pub-id><?supplied-pmid 27352072?><pub-id pub-id-type="pmid">27352072</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>A</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>J</given-names></name></person-group>. <article-title>A novel unsaturated fatty acid hydratase toward C16 to C22 fatty acids from <italic>Lactobacillus acidophilus</italic></article-title>. <source>J Lipid Res.</source> (<year>2015</year>) <volume>56</volume>:<fpage>1340</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M059444</pub-id><?supplied-pmid 25966711?><pub-id pub-id-type="pmid">25966711</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YY</given-names></name><name><surname>Liang</surname><given-names>NY</given-names></name><name><surname>Curtis</surname><given-names>JM</given-names></name><name><surname>G&#x000e4;nzle</surname><given-names>MG</given-names></name></person-group>. <article-title>Characterization of linoleate 10-hydratase of <italic>Lactobacillus plantarum</italic> and novel antifungal metabolites</article-title>. <source>Front Microbiol.</source> (<year>2016</year>) <volume>7</volume>:<fpage>1561</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.01561</pub-id><?supplied-pmid 27757104?><pub-id pub-id-type="pmid">27757104</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>WR</given-names></name><name><surname>Seo</surname><given-names>MJ</given-names></name><name><surname>Shin</surname><given-names>KC</given-names></name><name><surname>Park</surname><given-names>JB</given-names></name><name><surname>Oh</surname><given-names>DK</given-names></name></person-group>. <article-title>Comparison of biochemical properties of the original and newly identified oleate hydratases from <italic>Stenotrophomonas maltophilia</italic></article-title>. <source>J Appl Environ Microbiol.</source> (<year>2017</year>) <volume>83</volume>:<fpage>e03351</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.03351-16</pub-id><?supplied-pmid 28235876?><pub-id pub-id-type="pmid">28235876</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>S</given-names></name><name><surname>Simeis</surname><given-names>DD</given-names></name></person-group>
<article-title>Use of <italic>Lactobacillus rhamnosus</italic> (ATCC 53103) as whole-cell biocatalyst for the regio-and stereoselective hydration of oleic, linoleic, and linolenic acid</article-title>. <source>Catalysts.</source> (<year>2018</year>) <volume>8</volume>:<fpage>109</fpage>
<pub-id pub-id-type="doi">10.3390/catal8030109</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>12-HHT</term><def><p>12-hydroxy-heptadecatrienoic acid</p></def></def-item><def-item><term>14,15-EpETE</term><def><p>14,15-epoxyeicosatetraenoic acid</p></def></def-item><def-item><term>17,18-EpETE</term><def><p>17,18-epoxyeicosatetraenoic acid</p></def></def-item><def-item><term>17,18-diHETE</term><def><p>17,18-dihydroxy-eicosatetraenoic acid</p></def></def-item><def-item><term>AA</term><def><p>arachidonic acid</p></def></def-item><def-item><term>CHS</term><def><p>contact hypersensitivity</p></def></def-item><def-item><term>CLA</term><def><p>conjugated linoleic acid</p></def></def-item><def-item><term>COX</term><def><p>cyclooxygenase</p></def></def-item><def-item><term>CRTH2</term><def><p>chemoattractant receptor-homologous molecule expressed on Th2 cells</p></def></def-item><def-item><term>CYP</term><def><p>cytochrome P450</p></def></def-item><def-item><term>DC</term><def><p>dendritic cell</p></def></def-item><def-item><term>DHA</term><def><p>docosahexaenoic acid</p></def></def-item><def-item><term>DSS</term><def><p>dextran sodium sulfate</p></def></def-item><def-item><term>EPA</term><def><p>eicosapentaenoic acid</p></def></def-item><def-item><term>GPR</term><def><p>G-protein-coupled receptor</p></def></def-item><def-item><term>HYA</term><def><p>10-hydroxy-<italic>cis</italic>-12-octadecenoic acid</p></def></def-item><def-item><term>HYB</term><def><p>10-hydroxy-octadecanoic acid</p></def></def-item><def-item><term>HYC</term><def><p>10-hydroxy-<italic>trans</italic>-11-octadecenoic acid</p></def></def-item><def-item><term>IL</term><def><p>interleukin</p></def></def-item><def-item><term>KetoA</term><def><p>10-oxo-<italic>cis</italic>-12-octadecenoic acid</p></def></def-item><def-item><term>KetoB</term><def><p>10-oxo-octadecanoic acid</p></def></def-item><def-item><term>KetoC</term><def><p>10-oxo-<italic>trans</italic>-11-octadecenoic acid</p></def></def-item><def-item><term>LC</term><def><p>liquid chromatography</p></def></def-item><def-item><term>LOX</term><def><p>lipoxygenase</p></def></def-item><def-item><term>LT</term><def><p>leukotriene</p></def></def-item><def-item><term>MaR</term><def><p>maresin</p></def></def-item><def-item><term>MCRA</term><def><p>myosin cross-reactive antigen</p></def></def-item><def-item><term>MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term>NF</term><def><p>nuclear factor</p></def></def-item><def-item><term>OVA</term><def><p>ovalbumin</p></def></def-item><def-item><term>PD</term><def><p>protectin</p></def></def-item><def-item><term>PG</term><def><p>prostaglandin</p></def></def-item><def-item><term>PPAR</term><def><p>peroxisome proliferator-activated receptor</p></def></def-item><def-item><term>PUFA</term><def><p>polyunsaturated fatty acid</p></def></def-item><def-item><term>Rv</term><def><p>resolvin</p></def></def-item><def-item><term>SPM</term><def><p>specialized pro-resolving lipid mediator</p></def></def-item><def-item><term>TNF</term><def><p>tumor necrosis factor</p></def></def-item><def-item><term>TX</term><def><p>thromboxane.</p></def></def-item></def-list></glossary></back></article>